DPP-4 inhibitors: A promising feasible therapeutic approach for myocardial ischemia-reperfusion injury

被引：3
作者：
Yang, Chao-Jun
Yang, Jun
Yang, Jian
Fan, Zhi-Xing
机构：
[1] China Three Gorges Univ, Dept Cardiol, Coll Clin Med Sci 1, Yichang 443000, Hubei Province, Peoples R China
[2] China Three Gorges Univ, Inst Cardiovasc Dis, Yichang 443000, Hubei Province, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 201卷
基金：
中国国家自然科学基金;
关键词：
GLUCAGON-LIKE PEPTIDE-1; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; INFARCT SIZE;
D O I：
10.1016/j.ijcard.2015.08.112
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：253 / 254
页数：2
相关论文
共 10 条
[1]   Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia-reperfusion rat heart [J].
Chinda, Kroekkiat ;
Sanit, Jantira ;
Chattipakorn, Siriporn ;
Chattipakorn, Nipon .
DIABETES & VASCULAR DISEASE RESEARCH, 2014, 11 (02) :75-83
[2]   Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury [J].
Chinda, Kroekkiat ;
Palee, Siripong ;
Surinkaew, Sirirat ;
Phornphutkul, Mattabhorn ;
Chattipakorn, Siriporn ;
Chattipakorn, Nipon .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (02) :451-457
[3]   The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes [J].
Drucker, Daniel J. ;
Nauck, Michael A. .
LANCET, 2006, 368 (9548) :1696-1705
[4]   A hypothesis: Glucagon-like peptide-1 may play a protective role in diabetic cardiomyopathy [J].
Fan, Zhixing ;
Yang, Chaojun ;
Yang, Jian .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 197 :294-295
[5]   Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent function [J].
Gong, Quan ;
Rajagopalan, Sanjay ;
Zhong, Jixin .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 197 :170-179
[6]   Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner [J].
Hausenloy, Derek J. ;
Whittington, Hannah J. ;
Wynne, Abigail M. ;
Begum, Shah S. ;
Theodorou, Louise ;
Riksen, Niels ;
Mocanu, Mihaela M. ;
Yellon, Derek M. .
CARDIOVASCULAR DIABETOLOGY, 2013, 12
[7]   The novel DPP-4 inhibitors linagliptin and BI 14361 reduce infarct size after myocardial ischemia/reperfusion in rats [J].
Hocher, Berthold ;
Sharkovska, Yuliya ;
Mark, Michael ;
Klein, Thomas ;
Pfab, Thiemo .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (01) :87-93
[8]   An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury [J].
Ihara, Madoka ;
Asanuma, Hiroshi ;
Yamazaki, Satoru ;
Kato, Hisakazu ;
Asano, Yoshihiro ;
Shinozaki, Yoshihiro ;
Mori, Hidezo ;
Minamino, Tetsuo ;
Asakura, Masanori ;
Sugimachi, Masaru ;
Mochizuki, Naoki ;
Kitakaze, Masafumi .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2015, 308 (10) :H1287-H1297
[9]   Genetic Deletion or Pharmacological Inhibition of Dipeptidyl Peptidase-4 Improves Cardiovascular Outcomes After Myocardial Infarction in Mice [J].
Sauve, Meghan ;
Ban, Kiwon ;
Momen, M. Abdul ;
Zhou, Yu-Qing ;
Henkelman, R. Mark ;
Husain, Mansoor ;
Drucker, Daniel J. .
DIABETES, 2010, 59 (04) :1063-1073
[10]   DPP4 in Cardiometabolic Disease Recent Insights From the Laboratory and Clinical Trials of DPP4 Inhibition [J].
Zhong, Jixin ;
Maiseyeu, Andrei ;
Davis, Stephen N. ;
Rajagopalan, Sanjay .
CIRCULATION RESEARCH, 2015, 116 (08) :1491-1504
1